Ironwood Pharmaceuticals Inc share price logo

Ironwood Pharmaceuticals Inc

NASDAQ: IRWD

Small Cap

$3.58

-0.09

(-2.45%)

as on

Ironwood Pharmaceuticals Inc Stock Performance

as on May 16, 2026 at 2:15 pm IST

  • Day's Low

    $3.47
    $3.58
    downward going graph

    3.07%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.53
    $5.78
    downward going graph

    85.28%

    Downside

    61.45%

    Upside

    downward going graph

Ironwood Pharmaceuticals Inc share price movements today

Previous Close
$3.67
Open
$3.55
Volume
2.0M
Day's Low - High
$3.47 - $3.58
52 Week Low - High
$0.53 - $5.78

Ironwood Pharmaceuticals Inc Historical Returns

1 Month Return
-17.32 %
3 Month Return
-20.44 %
1 Year Return
+ 528.07 %
3 Year Return
-64.55 %
5 Year Return
-69.35 %

Ironwood Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Ironwood Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$604.1M

EPS (TTM)

1.09

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

10.47%

PE Ratio (TTM)

5.92

Industry PE ratio

2.698478260869565

PEG Ratio

-0.26

EBITDA

203.9M

Revenue (TTM)

361.5M

Profit Margin

28.26%

Return On Equity TTM

-574.72%

Ironwood Pharmaceuticals Inc Stock Valuation

Track how Ironwood Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Ironwood Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (-22.60x)

March 31, 2025

Industry (2.70x)

May 16, 2026

Today (5.92x)

May 16, 2026

Highest (129.55x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 5.92x

Ironwood Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ironwood Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$604.1M-69.35%5.9228.26%
BUY$24.1BNA21.0140.62%
HOLD$20.1B3%NA-2.04%
BUY$39.7BNA17.9215.11%
BUY$31.1B-56.92%12.1728.04%

Stock Returns calculator for Ironwood Pharmaceuticals Inc Stock including INR - Dollar returns

The Ironwood Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ironwood Pharmaceuticals Inc investment value today

Current value as on today

₹7,04,871

Returns

₹6,04,871

(+604.87%)

Returns from Ironwood Pharmaceuticals Inc Stock

₹5,28,070 (+528.07%)

Dollar Impact

₹76,801 (+76.8%)

Analyst Recommendation on Ironwood Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Ironwood Pharmaceuticals Inc. Average target price of $6.1

Ironwood Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Ironwood Pharmaceuticals Inc.

What analysts predicted

41.31%UPSIDE

Target Price

$6.1

Current Price

$3.58

Analyzed by

12 Analysts

Target

$6.10

Ironwood Pharmaceuticals Inc target price $6.1, a slight upside of 41.31% compared to current price of $3.58. According to 12 analysts rating.

Indian Investors' Interest in Ironwood Pharmaceuticals Inc Stock

Search interest for Ironwood Pharmaceuticals Inc Stock has increased by 104% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:104% versus previous 30 day period

Ironwood Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
117
74
94
91
90
41
85
122
47
106
Gross Profit
117
49
94
61
90
13
84
121
47
106
Operating Income
37
11
24
25
31
-29
45
77
6
72
EBITDA
40
11
26
27
33
-10
45
78
8
72
Interest Expense
8
7
7
9
8
8
8
8
7
9
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
30
4
18
17
23
-36
37
68
0
65
Income Tax Expense
32
9
19
13
21
1
14
27
2
24
Net Income
-1
-4
0
3
2
-37
23
40
-2
40
Net Profit Margin
-0.92%
-5.56%
-0.91%
3.98%
2.49%
-90.87%
27.69%
32.84%
-4.77%
38.28%

Ironwood Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
273
298
346
428
389
413
410
442
351
296
Gross Profit
272
278
313
293
386
343
409
436
343
296
Operating Income
-51
-77
-238
120
142
232
250
-945
93
118
EBITDA
-31
-33
-144
128
141
233
261
197
97
104
Interest Expense
39
36
37
36
29
31
7
21
33
32
Depreciation
-
14
14
5
3
1
1
1
2
1
Income Before Tax
-81
-116
-282
58
108
200
252
-948
65
70
Income Tax Expense
37
34
-5
74
2
-327
77
83
64
46
Net Income
-81
-116
-282
21
106
528
175
-1,002
0
24
Net Profit Margin
-29.83%
-39.20%
-81.46%
5.02%
27.26%
127.72%
42.64%
-226.37%
0.25%
8.11%

Ironwood Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-4
0
3
3
-37
23
40
61
40
Operating Cash Flow
44
33
9
15
19
-15
47
74
5
Investing Cash Flow
0
0
0
0
0
0
0
0
-
Financing Cash Flow
-15
-49
-27
-14
0
0
-
0
-
Change in Cash
29
-16
-17
0
19
-15
47
75
5

Ironwood Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-116
-282
21
106
528
175
-1,002
0
24
Operating Cash Flow
-99
-70
10
168
261
273
183
103
127
Investing Cash Flow
151
88
-11
-1
0
0
-1,026
0
0
Financing Cash Flow
19
30
-1
18
-4
-237
277
-106
0
Change in Cash
71
48
-1
185
257
36
-565
-3
126

Global Institutional Holdings in Ironwood Pharmaceuticals Inc

Funds
Holdings
Bank of America Corp
7%
Connor Clark & Lunn Inv Mgmt Ltd
1.21%
The Goldman Sachs Group Inc
0.77%
Sarissa Capital Management LP
9.67%
BlackRock Inc
7.77%

Ironwood Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 26 November

    Wed, 05:48 PM

    -

    Ironwood shares rise 1.3% after Medicare sets LINZESS price at $136 for 30-day supply, effective January 1, 2027.

Insights on Ironwood Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IRWD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -2.27M → 40.77M (in $), with an average increase of 105.6% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 47.70M → 106.50M (in $), with an average increase of 55.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 77.2% return, outperforming this stock by 142.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IRWD stock has moved down by -15.2%

About Ironwood Pharmaceuticals Inc

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and Apraglutide, a synthetic peptide long-acting analog of glucagon-like peptide-2 for short bowel syndrome patients dependent on parenteral support, as well as for acute graft versus host disease. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
OrganisationIronwood Pharmaceuticals Inc
Headquarters100 Summer Street, Boston, MA, United States, 02110
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Thomas A. McCourt
E-voting on sharesClick here to vote

Key Management of Ironwood Pharmaceuticals Inc

Name

Title

Mr. Ronald Silver

Senior VP, Corporate Controller & Principal Accounting Officer

Dr. Rosario Lobrutto M.B.A., M.S., Ph.D.

VP & Global Head of Technical Operations

Mr. John Minardo

Senior VP, Chief Legal Officer & Secretary

Dr. Michael Shetzline M.D., Ph.D.

Chief Medical Officer, Senior VP and Head of Research & Drug Development

Mr. Jeff Ruberti

Chief Strategy Officer

Mr. Thomas A. McCourt

CEO & Director

Mr. Gregory Martini

Senior VP, CFO & Investor Relations

Ms. Tammi Gaskins

Senior Vice President & Chief Commercial Officer.

FAQs

What is Ironwood Pharmaceuticals Inc share price today?

Ironwood Pharmaceuticals Inc share price today is $3.58 as on at the close of the market. Ironwood Pharmaceuticals Inc share today touched a day high of $3.58 and a low of $3.47.

What is the 52 week high and 52 week low for Ironwood Pharmaceuticals Inc share?

Ironwood Pharmaceuticals Inc share touched a 52 week high of $5.78 on and a 52 week low of $0.53 on . Ironwood Pharmaceuticals Inc stock price today i.e. is closed at $3.58,which is 38.06% down from its 52 week high and 579.19% up from its 52 week low.

What is Ironwood Pharmaceuticals Inc's market capitalisation today?

Ironwood Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Ironwood Pharmaceuticals Inc Stock (IRWD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ironwood Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ironwood Pharmaceuticals Inc Shares that will get you 0.4190 shares as per Ironwood Pharmaceuticals Inc share price of $3.58 per share as on May 16, 2026 at 8:45 am IST.

What is the minimum amount required to buy Ironwood Pharmaceuticals Inc Stock (IRWD) from India?

Indian investors can start investing in Ironwood Pharmaceuticals Inc (IRWD) shares with as little as ₹95.955 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.55 in Ironwood Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Ironwood Pharmaceuticals Inc share’s latest price of $3.58 as on May 16, 2026 at 8:45 am IST, you will get 2.7933 shares of Ironwood Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Ironwood Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Ironwood Pharmaceuticals Inc stock has given -69.35% share price returns and 30.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?